本页面由Tiger Trade Technology Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

13.67
-0.4500-3.19%
盘后13.41-0.2600-1.90%17:20 EDT
成交量:120.39万
成交额:1,648.32万
市值:11.91亿
市盈率:-7.31
高:14.13
开:13.75
低:13.34
收:14.12
52周最高:36.26
52周最低:2.86
股本:8,715.70万
流通股本:7,188.81万
量比:0.45
换手率:1.67%
股息:- -
股息率:- -
每股收益(TTM):-1.8700
每股收益(LYR):-1.8700
净资产收益率:-36.61%
总资产收益率:-21.42%
市净率:2.49
市盈率(LYR):-7.31

数据加载中...

2021/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/10

重要事件披露

8-K - Current report
2021/08/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/09

重要事件披露

8-K - Current report
2021/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/11

重要事件披露

8-K - Current report
2021/04/06

重要事件披露

8-K - Current report
2021/03/17

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/17

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/17

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/03

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/11/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/23

重要事件披露

8-K - Current report
2020/11/20

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/11/19

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/11/16

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933